Patients with newly diagnosed malignant lymphoma or multiple myeloma who reported depressive symptoms prior to the start of chemotherapy had poorer survival, researchers found.
Mutated ATM and unmutated IGHV were identified as potential early drivers of disease in treatment-naive patients with chronic lymphocytic leukemia.
The purpose of this study is to assess the safety, tolerability, and antitumor activity, as well as recommended dose of brentuximab vedotin in combination with a multiagent chemotherapy regimen.
ECIL 7 releases its guidelines for managing CMV infection in patients with hematologic malignancies and after HSCT.
Chromosomal abnormalities and serum lactate dehydrogenase level are factors included in the revised international staging system (R-ISS) for multiple myeloma.
View treatment regimens for Waldenstrom’s Macroglobulinemia/Lymphoplasmacytic Lymphoma, including combination therapies with bortezomib and more.
Access treatment regimens for peripheral T-cell lyphoma, which details the selection of agents such as CHOP-21, CHOEP-21, and more.
Find the latest treatment regimens for lyphoblastic lymphoma, including details about the standard and augmented Berlin-Frankfurt-Munster (BFM) regimen.
View treatment options for grade 1 and 2 follicular lymphoma, with options for first-line therapy, options for the infirm/elderly, and more.
Get current treatment regimens for extranodal NK/T-cell lymphoma, which details options such as radiotherapy plus DeVic and SMILE + radiotherapy.
